Sublingual vaccines based on wild-type recombinant allergens

European Annals of Allergy and Clinical Immunology

Volumn 38, Issue 7, 2006, Pages 247-249

  Van Overtvelt, L ^a   Razafindratsita, A ^a   St Lu, N ^a   Didierlaurent, A ^a   Batard, Th ^a   Lombardi, V ^a   Martin, E ^a   Moingeon, Ph ^a  

^a Stallergenes SA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIALLERGIC AGENT; COLECALCIFEROL; DEXAMETHASONE; OVALBUMIN; RECOMBINANT VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL POLARITY; CELL SPECIFICITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFECT; HELPER CELL; HUMAN; HUMAN CELL; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOCOMPETENT CELL; LACTOBACILLUS PLANTARUM; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; SCREENING TEST; VACCINATION; WILD TYPE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, SUBLINGUAL; ALLERGENS; ANIMALS; DENDRITIC CELLS; DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY, IMMEDIATE; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; T-LYMPHOCYTES; VACCINES;

EID: 33750212723     PISSN: 03979148     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Frew A.-J., Smith H.-E. - Sublingual immunotherapy. J Allergy Clin Immunol 2001;107:441-4.
2. Allam J.-P., Novak N., Fuchs C., Asen S., Berge S., Appel T., Geiger E., Kochan J.-R., Bieber T. - Characterization of dendritic cells from human oral mucosa: a new Langerhans cell type with high constitutive FC epsilon R1 expression. J Allergy Clin Immunol, 2003:112:141-148.
3. Blaser K., Akdis C. - Interleukin 10, T regulatory cells and specific allergy treatment. Clin Exp Allergy 2004;34:328-331.
4. Burdin N., Guy B., Moingeon P. - Immunological foundations to the quest for new vaccine adjuvants. Biodrugs. 2004:18:79-93.
5. Bellinghausen I., Brand U., Steinbrink K., Enk A.-H., Knop J., Saloga J.- Inhibition of human allergic T-cell responses by IL-10-treated dendritic cells: differences from hydrocortisone-treated dendritic cells. J Allergy Clin Immunol 2001:108:242-249.
6. Penna G., Adorini L. - 1 Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000:164:2405-2411.
7. Spisek R., Brazova J., Rozkova D., Zapletalova K., Sediva A., Bartunkova J. - Maturation of dendritic cells by bacterial immunomodulators. Vaccine 2004;22:2761-2768.
8. Batard T., Didierlaurent A., Chabre H., Mothes N., Bussieres L., Bohle B., Couret M-N., Ball T., Lemoine R, Focks Tejkl M., Chenal A., Clément G., Dupont F., Valent P., Krauth M.-T., André C., Valenta R., Moingeon P. - Characterization of recombinant wild-type Bet v 1 as a candidate vaccine against birch pollen allergy. Int. Arch. Allergy Immunol. 2005;136:239-247